N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide

C21H16N4OS — CID 90625833

IUPACN-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide
SMILESO=C(Cc1c[nH]c2ccccc12)Nc1ccccc1-c1cn2ccsc2n1
InChIInChI=1S/C21H16N4OS/c26-20(11-14-12-22-17-7-3-1-5-15(14)17)23-18-8-4-2-6-16(18)19-13-25-9-10-27-21(25)24-19/h1-10,12-13,22H,11H2,(H,23,26)
InChIKeyWCLAWDXFXSPSMS-UHFFFAOYSA-N
MW372.45 g/mol
LogP4.73
Rot. Bonds4

About N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide

N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide (PubChem CID 90625833) has the molecular formula C21H16N4OS and a molecular weight of 372.45 g/mol. Its IUPAC name is N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide.

Molecular Properties

Compound NameN-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide
PubChem CID90625833
Molecular FormulaC21H16N4OS
Molecular Weight372.45 g/mol
Exact Mass372.10
IUPAC NameN-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide
SMILESO=C(Cc1c[nH]c2ccccc12)Nc1ccccc1-c1cn2ccsc2n1
InChIInChI=1S/C21H16N4OS/c26-20(11-14-12-22-17-7-3-1-5-15(14)17)23-18-8-4-2-6-16(18)19-13-25-9-10-27-21(25)24-19/h1-10,12-13,22H,11H2,(H,23,26)
InChIKeyWCLAWDXFXSPSMS-UHFFFAOYSA-N
XLogP4.73
TPSA62.19 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500372.45
LogP ≤ 54.73
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-[4-(trifluoromethyl)phenyl]acetamide
CID 90625995
2-(1H-indol-3-yl)-N-(2-thiophen-2-ylphenyl)acetamide
CID 17398563
2-(1H-indol-3-yl)-N-[2-(6-oxo-1H-pyridazin-3-yl)phenyl]acetamide
CID 71804974
2-(4-chlorophenoxy)-N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)acetamide
CID 90625722
(E)-N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)but-2-enamide
CID 90625813
N-imidazo[1,2-a]pyridin-8-yl-2-(1H-indol-3-yl)acetamide
CID 110745727
N-[2-(hydroxymethyl)phenyl]-2-(1H-indol-3-yl)acetamide
CID 60653710
2-fluoro-N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)benzamide
CID 90625740
N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-9H-xanthene-9-carboxamide
CID 90625760
2-(1H-indol-3-yl)-N-(2-oxo-1H-pyridin-3-yl)acetamide
CID 51101093
2-(1H-indol-3-yl)-N-(1H-indol-4-yl)acetamide
CID 110745009
N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-3,4-dimethylbenzamide
CID 90625793

Frequently Asked Questions

What is the IUPAC name of N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide?
The IUPAC name of N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide (CID 90625833) is N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide.
What is the SMILES notation for N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide?
The canonical SMILES for N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide is O=C(Cc1c[nH]c2ccccc12)Nc1ccccc1-c1cn2ccsc2n1.
What is the InChIKey of N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide?
The InChIKey is WCLAWDXFXSPSMS-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H16N4OS/c26-20(11-14-12-22-17-7-3-1-5-15(14)17)23-18-8-4-2-6-16(18)19-13-25-9-10-27-21(25)24-19/h1-10,12-13,22H,11H2,(H,23,26).
What are the key properties of N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide?
N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide has a molecular weight of 372.45 g/mol, XLogP of 4.73, 4 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-imidazo[2,1-b][1,3]thiazol-6-ylphenyl)-2-(1H-indol-3-yl)acetamide is sourced from PubChem (CID 90625833), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).